MAZZARINO, Maria Clorinda
 Distribuzione geografica
Continente #
NA - Nord America 2.702
EU - Europa 1.233
AS - Asia 578
AF - Africa 177
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 3
SA - Sud America 1
Totale 4.702
Nazione #
US - Stati Uniti d'America 2.572
UA - Ucraina 426
CN - Cina 387
IE - Irlanda 378
SG - Singapore 139
CI - Costa d'Avorio 133
CA - Canada 128
IT - Italia 126
RU - Federazione Russa 102
DE - Germania 74
SE - Svezia 50
SN - Senegal 43
IR - Iran 17
GB - Regno Unito 16
IN - India 16
CH - Svizzera 14
FR - Francia 10
EU - Europa 8
NL - Olanda 8
AT - Austria 7
GR - Grecia 6
PL - Polonia 5
UZ - Uzbekistan 5
BE - Belgio 4
BG - Bulgaria 4
NZ - Nuova Zelanda 3
TR - Turchia 3
HK - Hong Kong 2
LB - Libano 2
VN - Vietnam 2
CO - Colombia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
ES - Italia 1
FI - Finlandia 1
GH - Ghana 1
JP - Giappone 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
MX - Messico 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 4.702
Città #
Jacksonville 514
Chandler 434
Dublin 378
Houston 312
Abidjan 133
Nanjing 119
Cambridge 112
Lawrence 111
Andover 110
Toronto 108
Des Moines 83
Singapore 78
Boardman 74
Ashburn 72
San Mateo 70
Catania 56
Grafing 51
Wilmington 45
Dakar 43
Hebei 37
Nanchang 36
Saint Petersburg 31
Jiaxing 26
Shenyang 26
Ottawa 19
Tianjin 19
Ardabil 15
Changsha 14
Beijing 13
Leawood 13
Bremen 11
Augusta 10
Norwalk 10
Florence 9
Jinan 9
Kunming 9
Monmouth Junction 9
Hangzhou 8
Ningbo 8
Moscow 7
Falls Church 6
San Francisco 6
Seattle 6
Den Haag 5
Guangzhou 5
Los Angeles 5
Brussels 4
Changchun 4
Dearborn 4
Kiev 4
Amsterdam 3
Ann Arbor 3
Bangalore 3
Lausanne 3
Liberty Lake 3
Mountain View 3
Taizhou 3
Washington 3
Zhengzhou 3
Dong Ket 2
Fremont 2
Maletto 2
Milan 2
Misterbianco 2
Padova 2
Priolo Gargallo 2
Pune 2
Tappahannock 2
Trecastagni 2
Acireale 1
Bangkok 1
Brno 1
Chiaramonte Gulfi 1
Clifton 1
Dartmouth 1
Edinburgh 1
Esslingen am Neckar 1
Frankfurt Am Main 1
Frankfurt am Main 1
Haikou 1
Hamilton 1
Hefei 1
Kamampa 1
Kyiv 1
Lanzhou 1
Lappeenranta 1
London 1
Lower Hutt 1
Ludwigshafen 1
Lutzingen 1
Maida Hill 1
Mumbai 1
Munich 1
Naples 1
Orlando 1
Palermo 1
Puntarenas 1
Redmond 1
Redwood City 1
San Severo 1
Totale 3.369
Nome #
Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders 278
The sex bias in systemic sclerosis: on the possible mechanisms underlying the female disease preponderance. 273
Effect of levofloxacin treatment on semen hyperviscosity in chronic bacterial prostatitis patients. 99
Autosomal recessive hypercholesterolemia in a Sicilian kindred harboring the 432insA mutation of the ARH gene 65
Beta-2-glycoprotein I is growth regulated and plays a role as survival factor for hepatocytes 65
BRAF G469S mutation as indicator of neoplastic transformation in workers with UV exposure 64
Absence of BRAF gene mutation in non-melanoma skin tumors 64
Analysis of hepatitis C virus infection among health-care workers: an observational study 60
PARTIAL LIPODYSTROPHY - IMMUNOLOGICAL STUDIES IN A SICILIAN GIRL 59
Proinflammatory circulating molecules in peripheral arterial disease 56
Advances in targeting signal transduction pathways. 56
B-cell neoplasia in the context of HCV infection: A distinct entity? 56
Analysis of G(-174) CIL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease 56
Soluble adhesion molecules and cytokines in children affected by recurrent infections of the upper respiratory tract 55
All trans retinoic acid sensitizes colon cancer cells to hyperthermia cytotoxic effects 55
IL-2 RECEPTORS, NK AND LAK CYTOTOXICITY OF LYMPHOCYTES IN BREAST-CARCINOMA DURING PROLONGED THYMOPENTIN THERAPY 53
Association of TIMP-1 +372 SNP with digital ulcer manifestation in female systemic sclerosis patients 53
Detection of BRAF gene mutation in primary choroidal melanoma tissue 53
IL-1beta, TNF-alpha and IL-6 release from monocytes in haemodialysis patients in relation to dialytic age 52
GIT-27 NO may be a potential therapeutic agent for melanoma treatment by inhibition of the transcription repressor YIN-YANG 52
Analysis of BRAF mutation in primary and metastatic melanoma 51
Efficacy of an analysis of lymphocyte subsets in predicting the clinical response to alpha-interferon therapy in thalassaemia patients with chronic infection by hepatitis C virus: a pilot study 50
Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in type II diabetics with peripheral arterial disease 50
Serum concentrations of the interferon-gamma-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease 50
Association between rs2294020 in X-linked CCDC22 and susceptibility to autoimmune diseases with focus on systemic lupus erythematosus 50
Analysis of MMP-9 gene polymorphism 1562C/T in patients suffering from systemic sclerosis with and without ulcers 49
Defective function of the fas apoptotic pathway in type 1 diabetes mellitus correlates with age at onset 48
Vitamin D3: an ever green molecule 48
S100A7: A rAMPing up AMP molecule in psoriasis 47
Co-regulated expression of matrix metalloproteinase-2 and transforming growth factor-beta in melanoma development and progression 46
Role of Hypoxia and Autophagy in MDA-MB-231 Invasiveness 46
Computational Evaluation of Yin Yang 1 Transcript Levels in the Spectrum of B-cell Neoplasia 46
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance 46
Jagged-1 expression is downregulated in skin from biologic-treated psoriatic patients 45
Role of BRAF mutations in hematopoietic malignancies and the induction of cytokine-independence-synergy with PI3K/Akt pathway 44
Regulation of drug and immune resistance by YY1 in cancer 44
Effect of alpha-interferon on natural killer cell activity and lymphocyte subsets in thalassemia patients with chronic hepatitis C 44
Evaluation of circulating CD4⁺CD25⁺ and liver-infiltrating Foxp3⁺ cells in HCV-associated liver disease 44
High circulating levels of cytokines (IL-6 and TNFalpha), adhesion molecules (VCAM-1 and ICAM-1) and selectins in patients with peripheral arterial disease at rest and after a treadmill test 44
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging 44
Altered pattern of circulating matrix metalloproteinases -2,- 9 and tissue inhibitor of metalloproteinase -2 in patients with HCV-related chronic hepatitis. Relationship to histological features 44
Liver immunolocalization and plasma levels of MMP-9 in non-alcoholic steatohepatitis (NASH) and hepatitis C infection 43
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance. 43
CD155/Neel-5 immunolocallization in melanocytic skin lesions 43
IL2 and its receptors in elderly subjects on hemodialysis 42
CIRCULATING IMMUNOCOMPLEXES AND LARYNGEAL CARCINOMA 42
Analysis of matrix metalloproteinase-9 gene polymorphism-1562 C/T in patients suffering from systemic sclerosis with and without ulcers 42
Cell death in human acute myelogenous leukemic cells induced by pyrrolidinedithiocarbamate 42
Activation of the Osteopontin/Matrix Metalloproteinase-9 Pathway Correlates with Prostate Cancer Progression 42
Persistent high plasma levels of interleukins 18 and 4 in children with recurrent infections of the upper respiratory tract 42
IL-18 nelle infezioni virali ricorrenti in età pediatrica 41
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response 40
Sensitization of cancer stem cells based on inhibiting key signal transduction pathways 40
Analysis of osteopontin and matrix metalloproteinase-9 in prostate cancer 40
Behavior of complement and anti-complement factors in the course of hepatic regeneration and degeneration 39
Biologically induced improvement of PASI score is associated with a decline of S100A7 expression in psoriatic skin lesions. A preliminary immunohistochemical study 39
Role of tissue inhibitor of metalloproteinases-1 in the development of autoimmune lymphoproliferation 39
Genetic polymorphisms of FOXP3 in Italian patients with systemic sclerosis 38
Rituximab for treatment of lymphoproliferative disorders associated with hepatitis C virus (HCV) infection 38
Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells 38
Matrix metalloproteinases and their inhibitors as markers of inflammation and fibrosis in chronic liver disease 37
Osteopontin/Matrix metalloproteinases pathway is not activated in cervical carcinoma 37
Isoproterenol treatment modulates matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor-2 (TIMP-2) expression in rat parotid gland 36
Hormones are key actors in gene x environment interactions programming the vulnerability to Parkinson's disease: glia as a common final pathway 36
Detection of bcl-2 rearrangement in mucosa-associated lymphoid tissue lymphomas from patients with hepatitis C virus infection 35
Novel NO-donating compound GIT-27NO possesses strong tumoricidal capacity in vitro and in vivo 35
Contribution of Immunohistochemistry in Revealing S100A7/JAB1 Colocalization in Psoriatic Epidermal Keratinocyte 35
Uterine cervical carcinoma: Role of matrix metalloproteinases (Review) 33
Isoproterenol modulates matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor-2 (TIMP-2) in rat parotid gland 33
Insight into the role of microRNAs in brain tumors (review) 33
Biological therapy induces expression changes in Notch pathway in psoriasis 33
Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer 32
Modulation of Chitotriosidase During Macrophage Differentiation 32
Osteopontin gene haplotypes correlate with multiple sclerosis development and progression 32
Effects of adalimumab, etanercept and ustekinumab on the expression of psoriasin (S100A7) in psoriatic skin 32
Long pentraxin 3: a marker of inflammation in untreated psoriatic patients 31
Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappa B inhibitor, prevents inflammatory injury induced by interferon-gamma and histamine in NCTC 2544 keratinocytes 31
Expression and localisation of osteopontin and prominin-1 (CD133) in patients with endometriosis 31
Immunohistocemical localization of NECL-5 in melanocytic skin lesions. Preliminary observations 31
Analysis of TIMP-1 gene polymorphisms in Italian sclerodermic patients 31
S100A7, Jab1, and p27 kip1 expression in psoriasis and S100A7 CRISPR-activated human keratinocyte cell line 31
High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation 30
Biological therapy downregulates the heterodimer S100A8/A9 (calprotectin) expression in psoriatic patients 30
Immunolocalization of FOXP3 in HCV-infected liver biopsies. Preliminary observations 29
CD155/Necl-5 immunolocalization in melanocytic skin lesions 29
Preoperative rIL-2 treatment in renal cancer: Early and late effects on lymphocyte subsets and proliferation, NK activity, IL-6 in vivo and in vitro production 29
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health 29
MAPK and AKT pathways are activated in melanoma by BRAF, NRAS and PIK3CA mutations 29
Inhibition of GSK-3 beta activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in breast cancer 28
Osteopontin and matrix metalloptroteinase-9 as markers of early detection of prostate cancer development 28
Expression and localization of prominin-1 in isoproterenol-treated rat parotid gland 28
Jagged-1/Notch-1/Hes-1 pathway in psoriatic patients: effects of biological therapy 28
Venous stasis causes release of interleukin 1β (IL - 1β), interleukin 6 (IL – 6) and tumor necrosis factor alpha (TNFα) by monocite macrophage 27
Lack of association of rs3761549 and rs5902434 polymorphisms of FOXP3 gene with risk of systemic sclerosis in the Italian population: A case-control study 27
Prognostic significance of YY1 in High Grade Lymphomas 26
S100A7 in psoriasis: Immunodetection and activation by CRISPR technology 26
Understanding rituximab function and resistance: implications for tailored therapy 25
Frequency of bcl-2/IgH translocation in patients with non-Hodgkin's lymphoma and chronic hepatitis C virus infection 25
Nectin like-5 overexpression correlates with the malignant phenotype in cutaneous melanoma 25
FOXP3, ICOS and ICOSL gene polymorphisms in systemic sclerosis: FOXP3 rs2294020 is associated with disease progression in a female Italian population 25
Totale 4.597
Categoria #
all - tutte 15.842
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.842


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.062 275 73 197 98 130 20 96 0 59 28 72 14
2020/2021779 8 58 103 2 175 9 101 0 111 0 189 23
2021/2022823 106 111 0 8 130 6 117 23 77 0 16 229
2022/20231.235 122 56 24 110 135 220 2 212 289 14 39 12
2023/2024508 23 76 24 41 11 122 1 54 9 7 87 53
2024/202521 21 0 0 0 0 0 0 0 0 0 0 0
Totale 4.841